vs

Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and TOOTSIE ROLL INDUSTRIES INC (TR). Click either name above to swap in a different company.

CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $196.3M, roughly 1.2× TOOTSIE ROLL INDUSTRIES INC). TOOTSIE ROLL INDUSTRIES INC runs the higher net margin — 14.7% vs -35.0%, a 49.7% gap on every dollar of revenue. On growth, TOOTSIE ROLL INDUSTRIES INC posted the faster year-over-year revenue change (1.5% vs -23.6%). TOOTSIE ROLL INDUSTRIES INC produced more free cash flow last quarter ($61.0M vs $16.1M). Over the past eight quarters, TOOTSIE ROLL INDUSTRIES INC's revenue compounded faster (13.2% CAGR vs -21.0%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.

CCRN vs TR — Head-to-Head

Bigger by revenue
CCRN
CCRN
1.2× larger
CCRN
$236.8M
$196.3M
TR
Growing faster (revenue YoY)
TR
TR
+25.1% gap
TR
1.5%
-23.6%
CCRN
Higher net margin
TR
TR
49.7% more per $
TR
14.7%
-35.0%
CCRN
More free cash flow
TR
TR
$44.9M more FCF
TR
$61.0M
$16.1M
CCRN
Faster 2-yr revenue CAGR
TR
TR
Annualised
TR
13.2%
-21.0%
CCRN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCRN
CCRN
TR
TR
Revenue
$236.8M
$196.3M
Net Profit
$-82.9M
$28.8M
Gross Margin
35.7%
Operating Margin
-30.2%
17.0%
Net Margin
-35.0%
14.7%
Revenue YoY
-23.6%
1.5%
Net Profit YoY
-2109.7%
27.9%
EPS (diluted)
$-2.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCRN
CCRN
TR
TR
Q4 25
$236.8M
$196.3M
Q3 25
$250.1M
$232.7M
Q2 25
$274.1M
$155.1M
Q1 25
$293.4M
$148.5M
Q4 24
$309.9M
$193.4M
Q3 24
$315.1M
$225.9M
Q2 24
$339.8M
$150.7M
Q1 24
$379.2M
$153.2M
Net Profit
CCRN
CCRN
TR
TR
Q4 25
$-82.9M
$28.8M
Q3 25
$-4.8M
$35.7M
Q2 25
$-6.7M
$17.5M
Q1 25
$-490.0K
$18.1M
Q4 24
$-3.8M
$22.5M
Q3 24
$2.6M
$32.8M
Q2 24
$-16.1M
$15.6M
Q1 24
$2.7M
$15.8M
Gross Margin
CCRN
CCRN
TR
TR
Q4 25
35.7%
Q3 25
20.4%
34.1%
Q2 25
20.4%
36.4%
Q1 25
20.0%
35.3%
Q4 24
39.1%
Q3 24
20.4%
34.1%
Q2 24
20.8%
33.5%
Q1 24
20.4%
32.7%
Operating Margin
CCRN
CCRN
TR
TR
Q4 25
-30.2%
17.0%
Q3 25
-2.4%
13.9%
Q2 25
-2.1%
7.8%
Q1 25
-0.3%
15.5%
Q4 24
-1.1%
20.0%
Q3 24
0.9%
15.6%
Q2 24
-5.7%
10.2%
Q1 24
0.8%
7.3%
Net Margin
CCRN
CCRN
TR
TR
Q4 25
-35.0%
14.7%
Q3 25
-1.9%
15.3%
Q2 25
-2.4%
11.3%
Q1 25
-0.2%
12.2%
Q4 24
-1.2%
11.6%
Q3 24
0.8%
14.5%
Q2 24
-4.7%
10.4%
Q1 24
0.7%
10.3%
EPS (diluted)
CCRN
CCRN
TR
TR
Q4 25
$-2.56
Q3 25
$-0.15
Q2 25
$-0.20
Q1 25
$-0.02
Q4 24
$-0.13
Q3 24
$0.08
Q2 24
$-0.47
Q1 24
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCRN
CCRN
TR
TR
Cash + ST InvestmentsLiquidity on hand
$108.7M
$176.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$322.8M
$941.0M
Total Assets
$449.0M
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCRN
CCRN
TR
TR
Q4 25
$108.7M
$176.6M
Q3 25
$99.1M
$119.8M
Q2 25
$81.2M
$170.5M
Q1 25
$80.7M
$176.6M
Q4 24
$81.6M
$194.6M
Q3 24
$64.0M
$163.2M
Q2 24
$69.6M
$131.2M
Q1 24
$5.2M
$159.4M
Stockholders' Equity
CCRN
CCRN
TR
TR
Q4 25
$322.8M
$941.0M
Q3 25
$408.1M
$918.9M
Q2 25
$412.2M
$893.1M
Q1 25
$418.2M
$879.4M
Q4 24
$419.0M
$870.7M
Q3 24
$424.7M
$870.2M
Q2 24
$433.3M
$841.4M
Q1 24
$462.4M
$834.4M
Total Assets
CCRN
CCRN
TR
TR
Q4 25
$449.0M
$1.3B
Q3 25
$538.2M
$1.2B
Q2 25
$553.8M
$1.2B
Q1 25
$576.2M
$1.1B
Q4 24
$589.3M
$1.1B
Q3 24
$597.4M
$1.1B
Q2 24
$602.9M
$1.1B
Q1 24
$648.4M
$1.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCRN
CCRN
TR
TR
Operating Cash FlowLast quarter
$18.2M
$73.3M
Free Cash FlowOCF − Capex
$16.1M
$61.0M
FCF MarginFCF / Revenue
6.8%
31.1%
Capex IntensityCapex / Revenue
0.9%
6.3%
Cash ConversionOCF / Net Profit
2.55×
TTM Free Cash FlowTrailing 4 quarters
$40.1M
$96.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCRN
CCRN
TR
TR
Q4 25
$18.2M
$73.3M
Q3 25
$20.1M
$62.2M
Q2 25
$4.2M
$-8.5M
Q1 25
$5.7M
$3.6M
Q4 24
$24.2M
$68.8M
Q3 24
$7.5M
$61.3M
Q2 24
$82.4M
$-12.6M
Q1 24
$6.0M
$21.4M
Free Cash Flow
CCRN
CCRN
TR
TR
Q4 25
$16.1M
$61.0M
Q3 25
$17.9M
$50.7M
Q2 25
$2.3M
$-16.0M
Q1 25
$3.8M
$750.0K
Q4 24
$21.7M
$64.7M
Q3 24
$6.3M
$55.8M
Q2 24
$79.6M
$-16.6M
Q1 24
$3.8M
$16.9M
FCF Margin
CCRN
CCRN
TR
TR
Q4 25
6.8%
31.1%
Q3 25
7.2%
21.8%
Q2 25
0.8%
-10.3%
Q1 25
1.3%
0.5%
Q4 24
7.0%
33.5%
Q3 24
2.0%
24.7%
Q2 24
23.4%
-11.0%
Q1 24
1.0%
11.0%
Capex Intensity
CCRN
CCRN
TR
TR
Q4 25
0.9%
6.3%
Q3 25
0.9%
5.0%
Q2 25
0.7%
4.8%
Q1 25
0.6%
1.9%
Q4 24
0.8%
2.1%
Q3 24
0.4%
2.4%
Q2 24
0.8%
2.6%
Q1 24
0.6%
2.9%
Cash Conversion
CCRN
CCRN
TR
TR
Q4 25
2.55×
Q3 25
1.74×
Q2 25
-0.49×
Q1 25
0.20×
Q4 24
3.06×
Q3 24
2.92×
1.87×
Q2 24
-0.81×
Q1 24
2.23×
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCRN
CCRN

Temporary Staffing Services$189.6M80%
Physician Staffing$42.5M18%
Other Services$4.7M2%

TR
TR

Products$194.3M99%
Rental And Royalty$1.9M1%

Related Comparisons